To investigate whether our subtyping method could predict the molecular characteristics of gliomas within both IDH wild‐type and mutant contexts, we stratified the RNA‐seq cohort based on IDH mutation status and subsequently analyzed the molecular features between high‐risk and low‐risk groups within each group. The gene discussed is IDH1; the disease is central nervous system cancer.